《新股表現》雲康(02325.HK)暗盤平開報7.89元
根據輝立交易平臺顯示,明天掛牌的雲康集團(02325.HK)暗盤平開報7.89元欠承接,掉頭低見7.46元,現報7.49元,較上市價7.89元,低5.1%,成交17萬股。
雲康是內地一家醫學營運服務提供商,爲醫療機構提供全套的診斷檢測服務。是次來港上市,以每股7.89元合共發售逾1.38億股(包括2,499.95萬股舊股),並已引入Harvest及亞輝龍香港作爲基石投資者,合共認購3,779.15萬股;其中10%公開發售獲約0.35倍超購,人人有份,料集資淨額約7.61億元,其中55%擬用作未來4年擴大並深化醫聯體網絡,約20%於未來3年用作提升公司醫學營運服務提供商的營運能力,約10%用作未來擴大公司於關鍵技術的診斷能力,約5%用作尋找潛在投資及收購機會。上市聯席保薦人分別招銀國際及浦銀國際。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.